• 7 (re)new(ed) strategic partnerships push flanders.bio forward into 2022

    10 hours ago

  • Biotalys and Olon enter into long-term partnership for the production of protein-based biocontrols

    Wednesday January 12th 2022

  • Biohaven enters exclusive license and research collaboration agreement with KU Leuven to advance first-in-class TRPM3 antagonists for the treatment of pain

    Wednesday January 12th 2022

  • Biotalys and Biobest enter into strategic partnership to expand reach of novel biocontrol solutions

    Monday December 20th 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Lonza and Bioqube Ventures sign a framework agreement for the future development and manufacture of biologics and small molecules for Bioqube’s portfolio companies

    Tuesday November 30th 2021

  • Confo Therapeutics enters collaborative agreement with Regeneron

    Tuesday November 30th 2021

  • FIT and its 21-strong partner team go all out for more internationalization, growth and prosperity

    Thursday November 25th 2021

  • Your news here?

  • GSK and imec to collaborate on disruptive innovation in pharma

    Tuesday November 9th 2021

  • reMYND and the US NINDS Epilepsy Therapy Screening Program (ETSP) begin collaboration on epilepsy program

    Monday November 8th 2021

  • X-Pure®–by-design : Antleron-Rousselot® collaborative-development partnership

    Tuesday October 12th 2021


Strategic Partners